The innate immune system is crucial for eventual control of infections, but may also contribute to pathology. Listeria monocytogenes is an intracellular Gram-positive bacteria and a major cause of food-borne disease. However, important knowledge on the interactions between L. monocytogenes and the immune system is still missing. Here, we report that Listeria DNA is sorted into extracellular vesicles (EVs) in infected cells and delivered to bystander cells to stimulate the cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)-stimulator of interferon genes (STING) pathway. This was also observed during infections with Francisella tularensis and Legionella pneumophila. We identify the multivesicular body protein MVB12b as a target for TANK-binding kinase 1 phosphorylation, which is essential for the sorting of DNA into EVs and stimulation of bystander cells. EVs from Listeria-infected cells inhibited T-cell proliferation, and primed T cells for apoptosis. Collectively, we describe a pathway for EV-mediated delivery of foreign DNA to bystander cells, and suggest that intracellular bacteria exploit this pathway to impair antibacterial defence.
L isteria monocytogenes is an intracellular Gram-positive bacteria and the causative agent of listeriosis, which often occurs during pregnancy, immunosuppression or extremes of age 1 . L. monocytogenes is taken up into cellular vacuoles, from which the bacteria escape through the action of the cytolysin listeriolysin O, thus allowing replication in the cytoplasm 2 . The immune system is essential for control of infection, with both innate and adaptive components being important. For instance, mice lacking the cytokine tumour necrosis factor α (TNFα) or MyD88-a central adaptor in the induction of TNF expression-are highly susceptible to L. monocytogenes infection 3, 4 . Likewise, T cells are essential for sterilizing immunity, and for long-term protection 5 .
In addition to the protective actions of the immune system, it also contributes to pathology. The cytokine interferon β (IFN-β), components in the IFN-β induction pathway and the IFN-α/β receptor are known to increase susceptibility to Listeria disease [6] [7] [8] [9] . Therefore, full understanding of the mechanisms that govern the IFN pathway during Listeria infection may provide knowledge that can be used therapeutically. Nucleic acids are potent stimulators of the production of type I IFNs 10 . Nucleic acids can be sensed in endosomes by Toll-like receptors (TLRs), with TLRs 3 and 7/8 detecting RNA, and TLR9 detecting DNA 11 . In the cytoplasm, RNA is detected by the DEAD-box helicases RIG-I and MDA5, and signal via the adaptor protein MAVS (mitochondrial antiviral-signalling protein) 12, 13 , while DNA is detected by cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) and signals via stimulator of IFN genes (STING) 14, 15 . Downstream of the adaptor protein, the pathways merge at the kinase TANK-binding kinase 1 (TBK1), which phosphorylates the transcription factor IFN regulatory factor 3 (IRF3) to activate the transcription of type I IFN genes. In T cells, the cGAS-STING pathway induces little or no type I IFN expression [16] [17] [18] , but inhibits proliferation and induces cell death [17] [18] [19] .
We previously reported that L. monocytogenes induces IFN-β expression in human macrophages through the cGAS-STING pathway 20 , and other reports have suggested that bacterial cyclicdi-nucleotides and bacterial RNA can also stimulate IFN-β expression 21, 22 . Thus, cells infected with L. monocytogenes can be activated through a range of innate immune pathways. However, there is limited knowledge on whether L. monocytogenes infection stimulates innate immune responses in bystander cells, what mechanisms may be involved and what the functional impact is.
Results
Supernatants from cells infected with intracellular bacteria contain IFN-inducing potential. We were interested in exploring whether infected cells are able to send signals to non-infected cells, thus propagating immune responses. To this end, we used a setup in which one set of cells (called donor cells; red) were infected with L. monocytogenes, and supernatants were subsequently harvested and transferred to a second set of cells (called recipient cells; blue), which were analysed for immune activation (Fig. 1a ). The supernatants from the infected cells induced strong Ifnb expression in wild-type recipient mouse embryonic fibroblasts (MEFs), despite the lack of live bacteria in the supernatants, and irrespective of whether donor cells were treated with chloramphenicol or gentamicin ( Fig. 1b and Supplementary Fig. 1a,b) . We observed minimal cell death in the donor cells under these experimental conditions ( Supplementary Fig. 1c ), and treatment of donor cells with the pancaspase inhibitor Z-VAD-FMK during infection did not affect the stimulation of recipient cells ( Supplementary Fig. 1d ). Initiation of gentamicin treatment as early as 1 h post-infection of donor cells did not affect the ability of supernatants to stimulate recipient cells ( Supplementary Fig. 1e ). In contrast with the induced Ifnb expression, interleukin-1β (IL-1β) production was not induced in cells receiving supernatants from Listeria-infected cultures (Fig. 1c) . The observed induction of Ifnb messenger RNA (mRNA) and Ifna4 mRNA in recipient cells was dependent on the presence of cells in the donor cell tissue dishes ( Supplementary Fig. 1f ), and was not explained by the transfer of bacteria or bacterial products targeting TLRs ( Supplementary Fig. 1g ).
The ability of bacteria-infected cells to transfer IFN-inducing potential to bystander cells was dose dependent, since we observed correlation between the infection dose and (1) the degree of bacterial infection in the donor cells, (2) the induction of Ifnb expression in donor cells and (3) the induction of Ifnb expression in recipient cells ( Supplementary Fig. 1h-j) . Importantly, supernatants from human M a v s -/-S t i n g g t/ g t W i l d t y p e S t i n g g t/ g t S t i n g g t/ g t S t i n g g t/ g t W i l d t y p e W i l d t y p e 7 0 
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infected with L. monocytogenes stimulated IFNB expression and type I IFN bioactivity, respectively, in recipient cells (Fig. 1d,e ). Finally, we found that the phenomenon was not restricted to L. monocytogenes infection, since supernatants from MEFs infected with Francisella tularensis or Legionella pneumophila also induced Ifnb expression in recipient cells ( Fig. 1f and Supplementary Fig. 1k ).
To investigate the nature of the transferable IFN-inducing entity, supernatants from infected MEFs were treated with DNase or RNase ( Supplementary Fig. 1l ). This treatment did not alter induction of Ifnb expression in recipient cells ( Fig. 1g ). Although nuclease treatment alone did not alter induction of Ifnb mRNA in recipient cells, the response was modestly reduced on heat treatment of the supernatants before addition onto recipient cells, and further reduced when heat was combined with DNase treatment (Fig. 1g ). To confirm the role for DNA in IFN-β induction in bystander cells, supernatants from L. monocytogenes-infected donor cells were used to stimulate wild-type, Mavs −/− and Goldenticket (gt) mutant Sting gt/gt recipient cells. Ifnb expression in the recipient cells was found to be dependent on STING but not MAVS (Fig. 1h ). The phenotypic differences between the cellular genotypes tested were unlikely to be due to clonal abnormalities ( Supplementary Fig. 1m-r) . Moreover, the ability of supernatants from L. monocytogenes-or F. tularensis-infected cells to induce Ifnb expression in recipient cells was dependent on escape from vacuoles into the cytosol in donor cells ( Fig. 1j ). Finally, we found that infection of donor cells with an L. monocytogenes ActA-deletion mutant unable to mediate cell-cell spread via efferocytosis 23 did not alter the Ifnb induction in recipient cells ( Fig. 1k ).
Foreign intracellular DNA stimulates IFN-β expression in bystander cells via extracellular vesicles (EVs).
Based on these results, we decided to examine the role for EVs, such as exosomes, as the system responsible for the delivery of IFN-stimulating DNA to recipient cells. Exosomes are vesicles derived from the multivesicular bodies (MVBs) that contain cytoplasmic molecules, sorted in a controlled manner 24 . Wild-type bone marrow-derived macrophages (BMMs) were transfected with double-stranded DNA (dsDNA), and cultures were incubated overnight in the presence or absence of GW4869-an inhibitor of neutral sphingomyelinase (nSMase2) required for exosome biogenesis 25, 26 ( Supplementary  Fig. 2a ). Interestingly, Ifnb expression was induced in wild-type BMM recipient cells stimulated with supernatant from DNA-transfected or electroporated donor cells, and this response was abrogated by treatment of donor cells with GW4869 ( Fig. 2a and Supplementary  Fig. 2b ). GW4869 alone did not inhibit DNA-transfectionstimulated Ifnb expression per se ( Supplementary Fig. 2c ). In agreement with the data based on the nSMase2 inhibitor, supernatants from DNA-transfected MEFs stably knocked out for nSMase2 had significantly reduced capacity to induce Ifnb expression in wildtype MEF recipient cells, and exosomes from these cells had significantly decreased levels of CD63 and CD81 compared with the wild type (Fig. 2b,c and Supplementary Fig. 2a,d ). Supernatants from DNA-transfected wild-type cells retained the capacity to induce Ifnb expression in IFN-α/β receptor-deficient recipient cells, and accordingly, recombinant IFN-β only marginally affected Ifnb expression in MEFs ( Supplementary Fig. 2e ,f). Together, these data argue for a role for EVs, and exclude a role for type I IFN, in the stimulation of IFN-β in recipient cells. Similar to bystander activation by Listeria-infected cells, recipient cells lacking STING were unable to induce Ifnb expression on treatment with supernatants from DNAtransfected cells (Fig. 2d ). Additionally, we tested cells deficient for cGAS and TBK1, which were incapable of inducing a response to the supernatant, whereas MAVS-deficient cells retained a normal response ( Fig. 2d ). We noted that supernatants from donor cells transfected with RNA were also able to stimulate IFN-β expression in recipient cells, and this was dependent on MAVS and TBK1 ( Fig. 2e ). Although TBK1 is also activated by cytokines and TLRs 27 , stimulation of these pathways in DNA-transfected Sting −/− donor cells enabled Ifnb induction in wild-type recipient cells ( Supplementary Fig. 2g ), suggesting the observed phenomenon to be a specific feature of cytoplasmic nucleic acid sensors. Finally, stimulation of Ifnb expression in recipient cells correlated with the length of the DNA transfected into donor cells ( Fig. 2f ).
To further examine whether EVs from DNA-transfected cells could deliver pathogen-associated molecular patterns (PAMPs) to adjacent cells, EVs were isolated from supernatants of transfected donor cells (Fig. 2g ). The EV-containing pellet and the remaining supernatants were used to stimulate wild-type MEF recipient cells. Importantly, recipient cells treated with the resuspended EV pellet exhibited high Ifnb expression, and this was abrogated if EVs were isolated from DNA-transfected donor cells treated with GW4869 ( Fig. 2h ), or if the recipient cells lacked cGAS ( Supplementary  Fig. 2h ). The residual Ifnb induction observed in response to the supernatant is probably explained by the fact that not all EVs are pelleted on ultracentrifugation ( Supplementary Fig. 2i ) 28 . In further support of foreign DNA being sorted into EVs in donor cells, we were able to detect fluorescein isothiocyanate (FITC) in CD63positive vesicles collected from FITC-DNA-transfected CD63-red fluorescent protein (RFP) MEFs ( Supplementary Fig. 2j ). Finally, we observed that recipient cells receiving supernatants from FITC-DNA-transfected donor cells were positive for FITC staining, and that it was the FITC + cells that contained nuclear IRF3 (Fig. 2i ). Collectively, these data, together with the requirement for cGAS in recipient cells, demonstrate that EVs are responsible for delivering DNA as the IFN-stimulating PAMPs from DNA-transfected donor cells to recipient cells.
Listeria infection activates EV-dependent stimulation of bystander cells.
The results above demonstrate that DNA is the PAMP in EVs from donor cells stimulated with synthetic DNA. However, L. monocytogenes produces cyclic di-AMP, which can stimulate STING directly 21, 29 . Therefore, we examined the requirement for cGAS in recipient cells receiving supernatants from infected cells, and also whether bacterial DNA was delivered to recipient cells. When supernatants from L. monocytogenes-infected wild-type cells were used to stimulate recipient cells deficient in either STING, cGAS, MAVS or TBK1, a high induction of Ifnb was observed in wild-type and MAVS-deficient cells, but not in cGAS-, STING-or TBK1-deficient cells (Fig. 3a ). Furthermore, when L. monocytogenes infection occurred in the presence of GW4869, supernatants from the donor cells failed to stimulate Ifnb expression in recipient cells (Fig. 3b ). GW4869 treatment did not affect L. monocytogenes replication in donor cells ( Supplementary Fig. 3a ). Intriguingly, inhibition of exosome biogenesis augmented IL-1β secretion by macrophages infected with L. monocytogenes ( Fig. 3c ), suggesting crosstalk between the cGAS and inflammasome pathways.
To examine whether bacterial DNA was sorted into EVs, we first isolated DNA from EVs in the supernatants from L. monocytogenesinfected cells, and visualized the DNA by atomic force microscopy (AFM). The linear topography of DNA with a measured height of ~1.5 nm was observed for the extended linear structures ( Fig. 3d and Supplementary Fig. 3b ), similar to that observed for plasmid DNA ( Supplementary Fig. 3c ). When analysing DNA from EVs of bacteria-infected cells using the automated Fragment Analyzer gel electrophoresis, we observed the DNA to be 700-10,000 base pairs (bp) and 400-1,500 bp depending on the markers used ( Fig. 3e and Supplementary Fig. 3d ). This analysis also showed that degradation of the DNA in the EVs was dependent on combined detergent and DNase treatment, thus confirming DNA to be located inside the EVs ( Supplementary Fig. 3d ). Finally, L. monocytogenes with EdC-labelled genomic DNA was used for infection of donor cells ( Supplementary Fig. 3e ). Using Click-iT chemistry in recipient cells, we were able to detect the transfer of bacterial DNA to the cytoplasm of recipient cells, with no detectable colocalization with the early endosome marker Rab7 (Fig. 3f) .
To assess the relative contribution of infected versus bystander cells to the total Ifnb expression, we infected MEFs with L. monocytogenes. Cells were harvested 6 and 18 h post-infection. From another set of donor cells, supernatants were harvested 18 h post-infection and used to stimulate wild-type recipient MEFs. Measurement of Ifnb mRNA in the different cell populations showed that the response evoked in the recipient cells was comparable to the response in the donor cells that were infected with the bacteria (Fig. 3g ). Similar results were obtained for F. tularensis infection and DNA transfection ( Fig. 3h and Supplementary  Fig. 3f ). Finally, to evaluate whether EVs also contributed to the Ifnb induced by L. monocytogenes in vivo, mice were treated with GW4869 before and during infection, and Ifnb expression was measured in the spleen. Importantly, inhibition of exosome biogenesis significantly reduced the levels of Ifnb mRNA and the IFN-stimulated gene Mx1 in the spleen of infected animals ( Fig. 3i and Supplementary Fig. 3g ), but not Tnfa mRNA (Fig. 3j ). The effect of GW4869 on Ifnb mRNA induction was not due to a general suppressive effect on Ifnb transcription, since Ifnb mRNA levels in the spleen after TLR9 agonist treatment were not affected ( Supplementary Fig. 3h ). Collectively, these results demonstrate that EV-mediated DNA transfer to bystander cells occurs during infection with intracellular bacteria.
EVs mediate STING-dependent apoptosis in T lymphocytes.
The pro-bacterial activity of the type I IFN system has been ascribed partly to a pro-apoptotic activity in T lymphocytes [6] [7] [8] [9] . In addition, STING-dependent signalling in T lymphocytes has recently been reported to impair proliferation and induce cell death in this cell type 18 . To investigate whether DNA-containing EVs from L. monocytogenes-infected cells were able to modulate T lymphocyte phenotypes through STING-dependent paracrine signalling, we treated T lymphocytes with Fas ligand (FasL) in the presence or absence of EVs from infected macrophages (Fig. 4a ). Interestingly, supernatants from L. monocytogenes-infected macrophages augmented FasL-stimulated apoptosis in splenic T lymphocytes, in a manner inhibited by GW4869 treatment of the macrophages and dependent on cGAS and STING expression in the T lymphocytes (Fig. 4b,c and Supplementary Fig. 4a,b ). The T cells did express cGAS and STING ( Supplementary Fig. 4c ). In a separate experimental setup, T lymphocytes were activated with anti-CD3 and anti-CD28 and subsequently treated with supernatants from L. monocytogenesinfected macrophages (Fig. 4d) . These experiments showed that Ifnb mRNA (normalized ratio) Ifnb mRNA (normalized ratio) EVs from infected cells also promoted apoptosis in activated T lymphocytes, and this was also dependent on STING expression in the lymphocytes (Fig. 4e,f) . Thus, activation of STING signalling in T lymphocytes by EVs from L. monocytogenes-infected cells promotes apoptosis.
To explore whether treatment with the nSMase2 inhibitor in vivo affected bacterial growth, we used a low dose of GW4869 that was tolerated by mice over the course of an eight-day period and still led to reduced Ifnb mRNA expression in the liver after L. monocytogenes infection ( Supplementary Fig. 4d,e ). Importantly, GW4869 treatment also enabled the mice to better control the bacteria, and was associated with significantly more expansion of T cells (Fig. 4g,h) . Thus, targeting of EVs through inhibition of nSMase2 reduces lymphocyte apoptosis and promotes antibacterial activity.
Foreign intracellular DNA is sorted into EVs in a STING-TBK1dependent manner. Next, we started to explore which cellular proteins were involved in the sorting of cytoplasmic DNA into EVs in donor cells. We observed that supernatants from DNA-transfected or L. monocytogenes-infected STING-or TBK1-deficient MEFs failed to stimulate Ifnb and Ifna4 mRNA expression or type I IFN bioactivity in wild-type recipient cells (Fig. 5a,b and Supplementary  Fig. 5a,b ). This phenotype was not rescued by pretreatment of the donor cells with IFN-β ( Supplementary Fig. 5c ). The requirement for STING in donor cells was also observed after infection with L. monocytogenes in human THP1 cells, and after infections with F. tularensis in MEFs ( Supplementary Fig. 5d,e ). Furthermore, FITC-labelled DNA was observed in wild-type recipient cells that received supernatant from wild-type donor cells transfected with FITC-labelled DNA, but not in wild-type recipient cells stimulated with supernatant from STING-and TBK1-deficient donor cells (Figs. 5c,d) , although the donor cells were transfected to similar efficiencies ( Supplementary Fig. 5f ). These data suggest that the STING-TBK1 axis is required for the sorting of cytoplasmic DNA into EVs.
To further investigate the role of STING in EV-mediated DNA transfer, we sought to determine whether STING is required for the actual formation of EVs. To this end, we isolated and characterized EVs from both wild-type and STING-deficient cells, but observed comparable levels of exosomal markers CD63 and CD81 (Fig. 5e ). Given that exosomes originate from multivesicular endosomes, and because STING can dock on perinuclear endosomes 14 , we investigated whether STING is required for the packaging of DNA into intraluminal vesicles in the endosome. DNA was extracted from EVs of wild-type and STING-deficient MEF cells infected with L. monocytogenes. We found that EVs derived from wild-type cells packaged bacterial DNA to a significantly greater extent than EVs derived from infected STING-deficient cells, as evaluated by AFM ( Fig. 5f,g) , deep sequencing ( Fig. 5h, Supplementary Fig. 5g and Supplementary Table 1 ) and PicoGreen DNA quantification (Fig. 5i ). Deep sequencing also revealed that the entire bacterial genome was represented in the EVs isolated from infected wild-type cells (Fig. 5j ). Collectively, these data demonstrate that the sorting of foreign DNA into EVs is dependent on STING.
MVB12b is an MVB phosphorylation target of TBK1 required for the transfer of DNA by EVs. Given the requirement for the STING-TBK1 axis in donor cells for the sorting of bacterial DNA into EVs, and for stimulation of bystander cells, we wanted to identify proteins in MVBs phosphorylated by TBK1. Therefore, we performed phosphoproteomics on MEFs transfected with dsDNA compared with untreated cells using stable isotope labelling with amino acids in cell culture (SILAC) 30 . Figure 6a shows the top 20 phosphorylated sites on dsDNA stimulation. The full dataset is available in Supplementary Table 2 . Interestingly, among the most strongly phosphorylated proteins, we identified MVB12b/ FAM125b, which is part of endosomal sorting complex required for transport I (ESCRT-I) 31 . ESCRT-I, which consists of Vps23, Vps28, Vps37 and MVB12, is involved in the generation of MVBs, and the recognition of cargo 31 . MVB12b was phosphorylated at Ser 222 ( Fig. 6b) , which is conserved between the human and mouse (Fig. 6c ). There is 96% amino acid homology between human and mouse MVB12b, suggesting that findings in the mouse system reflect human biology.
To examine the role of MVB12b in mediating bystander activation of the cGAS-STING pathway, we generated MVB12b-deficient MEFs (Fig. 6d ). Deletion of MVB12b did not impair the ability of cells to secrete EVs or to activate STING-dependent signalling ( Supplementary Fig. 6a,b) . Importantly, supernatants from Mvb12b −/− MEFs infected with L. monocytogenes or transfected or electroporated with DNA induced significantly less activation of Ifnb expression in recipient cells (Fig. 6e,f and Supplementary  Fig. 6c,d) . In agreement with this, supernatants from Mvb12b −/− donor MEFs transfected with FITC-DNA failed to deliver DNA into recipient wild-type MEFs, and EVs from infected Mvb12b −/− donor MEFs packaged reduced levels of DNA (Fig. 6g,h and Supplementary Fig. 6e ). To examine whether the phosphorylation of MVB12b was dependent on STING and TBK1, we compared phospho-S222 MVB12b levels in lysates from wild-type, Sting gt/gt and Tbk1 −/− cells. MVB12b was indeed phosphorylated after delivery of DNA into the cytoplasm, and this was dependent on STING and TBK1 ( Fig. 6i and Supplementary Fig. 6f ). Moreover, phospho-MVB12b colocalized with STING and DNA in the cytoplasm of L. monocytogenes-infected and DNA-transfected cells ( Fig. 6j and Supplementary Fig. 6g ). To ascertain the role of S222 in MVB12b in activating the cGAS-STING pathway, MVB12b-deficient MEFs were reconstituted with wild-type or S222A MVB12b, and infected with L. monocytogenes or transfected with DNA. Importantly, supernatants from cells reconstituted with wild-type MVB12b induced more Ifnb expression in recipient cells than supernatants from cells reconstituted with S222A MVB12b (Fig. 6k and Supplementary  Fig. 6h ). Thus, TBK1 phosphorylates Mvb12b to facilitate the sorting of cytoplasmic DNA into EVs.
Discussion
In this work, we show that DNA from intracellular bacteria is sorted into EVs through a STING-TBK1-MVB12b pathway and delivered to bystander cells to stimulate the cGAS-STING pathway. This enables danger signalling to spread across tissues before the infecting pathogen. In the case of L. monocytogenes, it is known that type I IFNs contribute to the pathology of infection [6] [7] [8] , and we found that EVs from L. monocytogenes-infected macrophages primed T cells for FasL-mediated apoptosis and also induced apoptosis in activated T cells. Thus, intracellular bacteria may exploit the STING-TBK1-MVB12b pathway to impair the antibacterial immune response, promoting establishment of infection.
Full orchestration of immune responses requires extensive interaction between cells. In addition to cytokines, there is an emerging appreciation of intercellular signals carrying information on the stress and infection status of donor cells. For instance, cyclic guanosine monophosphate-adenosine monophosphate can spread to adjacent bystander cells through gap junctions 32 , or be packaged into virus particles 33, 34 . In addition, EVs are capable of delivering cellular 35, 36 , as well as viral 37 , components across tissues, thereby designing the ensuring immune response. However, the exosome system can be exploited by pathogens. For instance, herpesviruses and hepatitis B virus deliver microRNAs to surrounding cells to shape the immune response and viral replication microenvironment 38, 39 . Our finding that EVs from L. monocytogenes-infected cells promote lymphocyte death and impair antibacterial activity in vivo suggests that intracellular bacteria take advantage of the EV machinery to dampen the immunological activity of T cells. The in vivo relevance of stimulation of the cGAS-STING pathway in recipient cells may go beyond T-cell death, since the type I IFN system has been reported to counteract the production of IL-17A, which promotes neutrophil expansion during F. tularensis infection 40 .
In addition to stimulation of type I IFN production through the cGAS-STING pathway, cytosolic DNA can activate the AIM2 and NLRP3 inflammasomes 41, 42 . Inflammasome activation leads to maturation of IL-1β and activation of pyroptosis. The AIM2 and NLRP3 inflammasomes have been reported to be important for the control of infections with L. monocytogenes and F. tularensis 43, 44 . Since both the AIM2 and cGAS pathways are stimulated by DNA, but activate downstream responses with opposing effects towards many intracellular bacterial infections, one important question relates to what determines whether a given species or population of DNA activates cGAS or AIM2. A comparative characterization of the requirements for activation of cGAS versus AIM2 could reveal regulatory differences between the two pathways that the bacteria may exploit to skew the DNA-activated responses towards a cGAS response. In support of this hypothesis, we found that levels of IL-1β in cultures from L. monocytogenes-infected murine macrophages and in spleens from infected mice were elevated if treated with GW4869, and that the DNA-containing EVs did not induce IL-1β production.
We found the mechanism of sorting of nucleic acids into EVs to be dependent on STING and TBK1. Moreover, we identified phosphorylation of S222 of MVB12b in donor cells as essential for the stimulation of STING signalling in recipient cells. These data strongly suggest that activated TBK1 targets ESCRT-I to promote the sorting of DNA into EVs. The mechanistic details of how cytoplasmic DNA is sorted into EVs through a specific mechanism dependent on TBK1-mediated phosphorylation of MVB12b at S222 remains to be uncovered. It has previously been reported that the sorting of hepatitis C virus RNA into exosomes is dependent on annexin A2, which has RNA-binding properties and is involved in membrane vesicle trafficking 37 .
In conclusion, we report that bacterial DNA in the cytoplasm can be sorted into EVs and delivered to bystander cells, leading to stimulation of the cGAS-STING pathway. The sorting of foreign DNA into EVs proceeds through a pathway dependent on STING, TBK1 and MVB12b. This paracrine signalling driven by bacterial DNA promotes the death of T lymphocytes and impairs antibacterial defence. Further understanding of the interplay between the AIM2-inflammasome and STING-IFN pathways may uncover how intracellular bacteria modulate DNA-stimulated immune responses for their own benefit.
Methods
Mice. For the in vivo treatment of mice with the exosome maturation inhibitor GW4869 (Sigma-Aldrich), 8-12-week-old C57BL/6N mice were injected intraperitoneally with GW4869 (0.3125 or 1.25 µg g bodyweight −1 ) or carrier control once per day for five consecutive days. On day 6, mice were intraperitoneally infected with 1 × 10 6 colony-forming units (c.f.u.) of L. monocytogenes (strain LO28). Bacterial inoculum was prepared as previously described 45 . At 24 h post-infection, mice were sacrificed and spleens were harvested. For c.f.u. assays, livers and spleens were weighed and homogenized in phosphate buffered saline (PBS), and 1:10 serial dilutions were plated on Oxford agar plates (Merck). Colonies were counted after approximately 30 h at 37 °C. Some mice were treated with ODN 1826 (InvivoGen) at a dose of 10 μg mouse −1 . Animals were housed under specific pathogen-free conditions according to Federation of European Laboratory Animal Science Associations guidelines, and animal experiments were approved by the Vienna University of Veterinary Medicine institutional ethics committee and performed according to protocols approved by Austrian law (BMWF 68.205/0032-WF/II/3b/2014).
Cell culture, transfections and transfer experiments.
Wild-type or genemodified MEFs were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (FBS), 100 U ml −1 penicillin, 100 μg ml −1 streptomycin and 2 mM l-glutamine. Murine BMMs were generated as described previously 46 . Briefly, bone marrow from mouse femurs and tibia were isolated and differentiated in the presence of granulocyte-macrophage colony-stimulating factor (40 ng ml −1 ) in 10 cm dishes. The media was replenished with Roswell Park Memorial Institute medium with 10% FBS and granulocytemacrophage colony-stimulating factor on days 3 and 7 post-isolation. PBMCs were isolated and cultured as previously described 47 . L929 cells were cultured in DMEM with 5% FBS and 100 U ml −1 penicillin, 100 μg ml −1 streptomycin and 2 mM l-glutamine. THP1 cells were cultured in Roswell Park Memorial Institute medium supplemented with 10% FBS, 100 U ml −1 penicillin, 100 μg ml −1 streptomycin and 2 mM l-glutamine. Cells were differentiated using phorbol 12-myristate 13-acetate (PMA) (200 nM) for 24 h. The PMA was washed off and cells were used for experiments 24 h later. Transfection of cells was performed using Lipofectamine 2000 or Amaxa 4D-Nucleofector according to manufacturer's instructions. The dsDNA used was a 60mer herpes simplex virus dsDNA. DNA fragments of varying sizes (NoLimits DNA fragments) were obtained from Thermo Fisher Scientific. A total of 2 × 10 5 cells ml −1 were seeded onto 24-well cell culture plates in 500 µl media. For transfer experiments, producer cells were washed 3 times 6 h after DNA transfection and fresh media was added. The supernatants were collected 18 h posttransfection, centrifuged at 300g for 5 min and transferred to recipient cells. 'Mock' indicates uninfected or Lipofectamine-transfected cells. When indicated, cells were treated with 10 μM GW4869 (D1692; Sigma-Aldrich). Only experiments in which positive and negative controls gave the expected results were further analysed and included in the study.
Culture and infection with L. monocytogenes, F. tularensis and L. pneumophila.
To culture L. monocytogenes (L028, 10403S, 2473, ΔLLO and ΔActA 48 ), a single clone from a blood agar plate was used to inoculate 5 ml of Brain Heart Infusion media. For Click-iT chemistry, bacteria were grown in Brain Heart Infusion media containing EdC. The absorbance was measured at 600 nm (A 600 nm ). An absorbance of 1 was considered equivalent to 2 × 10 9 c.f.u. ml −1 . Cells infected with L. monocytogenes (multiplicity of infection (MOI) = 200) for 6 h were treated with 50 µg ml −1 of gentamicin (catalogue number 010256; Sandoz) for 1 h to kill extracellular bacteria, after which the cells were washed 3 times and the media was replaced with media containing 10 µg ml −1 gentamicin and incubated overnight.
In some experiments, we used chloramphenicol (C0378; Sigma-Aldrich) instead of gentamicin. To inhibit caspase activation, cells were treated with Z-VAD-FMK (10 μM; InvivoGen) 30 min before infection. The compound was found to inhibit lipopolysaccharide + nigericin-induced IL-1β by more than 90% (not shown). F. tularensis subspecies novicida wild-type (U112) or ΔFPI mutant 49 strains were cultured in Tryptic Soy Broth supplemented with cysteine (0.1% w/v). MEFs were infected with a MOI of 400:1 by spinoculation (15 min, 2,000g at room temperature). At 4 h post-invasion, cells were washed twice with PBS, and the medium was replaced with medium containing 5 µg ml −1 gentamicin and incubated for an additional 20 h. L. pneumophila Corby wild type was grown on buffered charcoal-yeast extract agar plates at 37 °C for 3 d. Bacterial material was then inoculated in an appropriate volume of PBS, and A 600 nm was determined by an Ultrospec 10 Cell Density Meter (GE Healthcare). An A 600 nm of 1 corresponded to 2 × 10 9 bacteria ml −1 . The desired MOI was obtained by serial dilutions in PBS and, lastly, in cell-specific medium.
Genetic modification of MEFs by CRISPR-Cas9 and stable ectopic expression.
Guide RNAs of the sequences nSMase2a (1a6: TGCCCTCCACGCCGTGTCCT; 3b10: GCGACGAGGCTGCCAACGGC) and MVB12b (TCCCGACACTACCGGCTACCTTCCG) were cloned into pLentiCRISPR-v2. Third-generation lentiviral particles were used to transduce MEFs, and clones were selected using puromycin at a final concentration of 2 μg ml −1 .
For MEFs stable expressing CD63-RFP, cells were transduced with thirdgeneration lentiviral particles expressing plasmid pCT-CD63-RFP (CYTO120-PA-1-SBI; BioCat) and sorted for RFP + cells using a FACSAria III cell sorter. The cells were cultured under puromycin selection (2 μg ml −1 ) and clones were picked.
Evaluation of cell death. MEFs were infected with L. monocytogenes (MOI = 200) for 6 h, after which the cells were washed and treated with gentamicin (50 µg ml −1 ) for 1 h. The cells were then incubated overnight in media containing (10 µg ml −1 ) gentamicin. The next day, cells were trypsinized and stained with annexin V and propidium iodide (Dead Cell Apoptosis Kit with Annexin V Alexa Fluor 488 & Propidium Iodide; Thermo Fisher Scientific) according to the manufacturer's instructions. Fluorescence was measured using a NovoCyte Flow Cytometer, and analysis was performed using FlowJo version 10 (Tree Star).
Induction of apoptosis in T cells and analysis for annexin V.
CD3 + cells were isolated from mouse spleens using an EasySep kit from STEMCELL Technologies. To evaluate the effects of EVs from L. monocytogenes-infected cells on apoptosis in bystander cells, resting, apoptosis-induced (low concentration of FasL (5 ng ml −1 ); catalogue number F0427; Sigma-Aldrich), or activated (Human T-Activator CD3/CD28 Dynabeads; catalogue number 11161D; Thermo Fisher Scientific) T lymphocytes were treated with supernatants from macrophages infected for 18 h with L. monocytogenes (with or without GW4869). Apoptosis was evaluated by flow cytometry analysis with annexin V staining (Thermo Fisher Scientific).
Murine splenic cells were stained with CD3-PE, and T cells were sorted using the FACSAria III sorter. Isolated murine T cells were activated with Mouse T-activator CD3/CD28 (11456D; Thermo Fisher Scientific) for 48 h and lysed using radioimmunoprecipitation assay buffer (89901; Thermo Fisher Scientific). The lysates were subjected to western blotting.
Flow cytometry. Spleen cells were stained using fluorescently conjugated antibodies against CD19 (D3) and CD3 (17A2) (eBioscience). Fluorescence was measured using an LSRFortessa flow cytometer (BD Biosciences), and analysis was performed using FlowJo version 10 (Tree Star).
Enzyme-linked immunosorbent assay. Supernatants from cells were analysed for cytokine levels by enzyme-linked immunosorbent assay for murine cytokine IL-1β using matched antibody pairs obtained from R&D Systems, as described elsewhere 50 .
ImageStream. Fluorescence of EVs was detected and acquired using the ImageStream Mark II Imaging Flow Cytometer (Amnis). Isolated EVs were resuspended in 300 μl PBS and run at a low flow-rate setting. Particles for each measurement were excited at 200 mW using a 561 nm laser for CD63-RFPmRuby and a 488 nm laser for FITC. A 60× magnification was used for all samples. Bright-field images were acquired on channel 1, FITC on channel 2, CD63-RFP on channel 4 and side scatter images on channel 6. Data were analysed using IDEAS software version 6.2 (Amnis Corporation).
Enzyme treatment of supernatants and EVs. Supernatants of infected cells were centrifuged and treated with 10 μg RNase (EN0531; Thermo Fisher Scientific) or 10 units of recombinant DNase I (04716728001; Roche) in incubation buffer at 37 °C for 30 min before transferring to recipient cells. Supernatants that were heated at 70 °C were cooled to room temperature before treating with DNase as mentioned above. Mock was treated with DNase incubation buffer.
For analysis by Fragment Analyzer, EVs were treated with DNase I (18068-015; Thermo Fisher Scientific) according to the manufacturer's instructions. DNase I was inactivated with EDTA at 65 °C for 10 min. The sample was divided into 4 parts and treated with 1% NP-40 for 15 min on ice or 600 μg ml −1 Proteinase K for 20 min at 40 °C and inactivated at 70 °C for 20 min. The samples were then subjected to DNase treatment, as mentioned above, before DNA isolation using the Qiagen DNA Micro Kit (56304).
Confocal microscopy. Experiments were carried out on cells seeded on cover slips. Cells were fixed with ice-cold methanol for 5 min at −20 °C, washed with PBS and stained with 4′,6-diamidino-2-phenylindole (DAPI), following which they were mounted onto glass slides using ProLong Gold. For nuclear translocation and colocalization assays, cells were fixed and permeabilized with 4% paraformaldehyde and 0.1% Triton X. The cells were then blocked with 2.5% bovine serum albumin and stained with the following antibodies: Rab7 (9367; Cell Signaling), IRF3 (4302; Cell Signaling), STING (AF6516), phospho-S222 MVB12b (Antibody Production Services; GenScript) and corresponding secondary antibodies. Images were obtained on a Zeiss LSM 710 confocal microscope using a 63× 1.4 oil-immersion objective, and data were analysed using ImageJ software. For Click-iT chemistry, EdC-labelled (T511307; Sigma-Aldrich) DNA of bacteria were detected in fixed cells according to the manufacturer's instructions (C10337; Thermo Fisher Scientific), and Alexa Fluor 488 was detected under the microscope.
Phosphoproteomics. MEFs were SILAC labelled and stimulated with dsDNA. Cells were lysed in 4% sodium dodecyl sulfate and 10 mM HEPES pH 8.0 for 15 min at room temperature with sonication. Proteins were reduced with 10 mm dithiothreitol for 30 min and then subjected to alkylation for 45 min with 55 mm iodoacetamide in the dark. To remove detergent, acetone (−20 °C) was added to a final concentration of 80% (v/v), and proteins were precipitated for at least 2 h at −20 °C. The protein pellets were dissolved in 8 M urea and 10 mM HEPES pH 8.0. Digestion with LysC was carried out for 3 h at room temperature. Samples were diluted with 4 volumes of 50 mM ammonium bicarbonate, and further digested with trypsin overnight at room temperature. Peptides of DNA-stimulated and untreated cells with distinct isotopic labels were mixed 1:1. Samples were desalted with C18 and incubated with TiO2 beads (MZ-Analysentechnik) pre-incubated with dihydrobenzoic acid (Sigma-Aldrich). After incubation, beads were washed with 30% acetonitrile and 0.5% (v/v) trifluoroacetic acid in water, followed by a second wash with 80% acetonitrile with 0.1% trifluoroacetic acid. Phosphopeptides were eluted from beads with 15% NH 3 and desalted on C18 StageTips.
We separated peptides on an EASY-nLC 1000 high-performance liquid chromatography system (Thermo Fisher Scientific). Columns (75 μm inner diameter, 50 cm length) were packed in house with 1.9 μm C18 particles (Dr. Maisch). Peptides were loaded in buffer A (0.5% formic acid) and separated with a gradient from 5-30% buffer B (80% acetonitrile and 0.5% formic acid) for 120 min at 250 nl min −1 . The column temperature was set to 50 °C. A quadrupole Orbitrap mass spectrometer (Q Exactive; Thermo Fisher Scientific) was directly coupled to the liquid chromatograph via a nanoelectrospray source. The Q Exactive was operated in a data-dependent mode. The survey scan range was set to 300-1,650 m/z, with a resolution of 70,000 at m/z 200. Up to the 10 most abundant isotope patterns with a charge of ≥2 were subjected to higher-energy collisional dissociation with a normalized collision energy of 25, an isolation window of 3 Th and a resolution of 17,500 at m/z 200. To limit repeated sequencing, dynamic exclusion of sequenced peptides was set to 20 s. Thresholds for the ion injection time and ion target value were set to 20 ms and 3 × 10 6 for the survey scans, and 120 ms and 1 5 for the tandem mass spectrometry scans. Data were acquired using Xcalibur software (Thermo Fisher Scientific).
To process mass spectrometry raw files, we employed MaxQuant software (version 1.5.3.34) 51 . We used the Andromeda search engine (10.1021/pr101065j) integrated in MaxQuant to search tandem mass spectrometry spectra against the UniProtKB FASTA database (version from May 2014). Enzyme specificity was set to trypsin, allowing amino (N)-terminal cleavage to proline and up to two miscleavages. Peptides required a minimum length of seven amino acids for identification. Carbamidomethylation was set as a fixed modification, and acetylation (N terminus), methionine oxidation, and serine, threonine and tyrosine phosphorylation were set as variable modifications. A false discovery rate cutoff of 1% was applied at the peptide and protein levels. Initial precursor mass deviation of up to 4.5 ppm, and fragment mass deviation up to 20 ppm, were allowed. Furthermore, identifications were filtered for common contaminants (247 proteins) and identifications solely based on a modified site. Median SILAC ratios (of DNA-treated versus untreated cells) for phosphopeptides were calculated from four individual experiments (two with label swap). Phosphopeptides, which were quantified in fewer than two experiments or those with s.d. > 2 were excluded from the analysis.
Real-time quantitative PCR. mRNA was isolated using a High Pure mRNA isolation kit (Roche) according to the manufacturer's instructions. Quantitative PCR was performed on extracted mRNA using TaqMan primers for Ifnb1 (Mm00439552), Ifna4 (Mm00833969), Tnfa (Mn00443258_m1), FlaA (FlaA forward GTTCAATCTTGCAACGTATGCGTC, FlaA reverse CCACTACCTAAAGTGATTGTTCCAGCA) and bactin (Mm00607939). The relative fold induction of a sample was calculated relative to the mock treated sample using the ΔΔCt method.
Bioassays for human and murine type I IFN. Bioactive type I IFN was measured on cell supernatants using HEK-Blue IFN-α/β cells as reporter cells (InvivoGen) according to the manufacturer's instructions. Type I IFN was measured using a cell-based assay. Briefly, L929 cells were cultured in DMEM supplemented with 5% foetal calf serum and seeded into 96-well plates. Supernatant from stimulated bone marrow-derived dendritic cells was added as serial dilutions to the cells for 24 h at 37 °C alongside a positive control of mu-IFN-α (100 U ml −1 ). The next day, cells were infected with VSV/V10 and incubated until plaques were visible under a microscope. A 50% protection of virus-induced cell death in a well was used to define 1 U ml −1 of type I IFN.
Western blotting. Cells were lysed using radioimmunoprecipitation assay buffer in the presence of protease and phosphatase inhibitors. The centrifuged supernatants were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (Criterion TGX) and immunoblotting. Transfer to polyvinylidene difluoride membranes was carried out using a Trans-Blot Turbo Transfer System. The blots were blocked with 2.5% bovine serum albumin in PBS containing 0.1% Tween 20 before incubating with the following primary antibodies: CD81 (sc-9158; Santa Cruz), CD63 (sc-5275; Santa Cruz), calnexin (ab-22595; Abcam), nSMase2a (sc-166637; Santa Cruz), cGAS (SAB2100310; Sigma-Aldrich), STING (AF6516; R&D Systems), vinculin (V9131; Sigma-Aldrich) and horseradish peroxidaseconjugated actin (ab-49906; Abcam). Corresponding peroxidase-conjugated secondary antibodies were used (Jackson ImmunoResearch). Membranes were developed using SuperSignal West Dura extended duration substrate (34076; Thermo Fisher Scientific). Original blots are shown in Supplementary Fig. 7 .
Nanoparticle tracking analysis. Samples were measured using the NanoSight LM10 system (Malvern Instruments). Videos and data were analysed and recorded using the NTA software (version 3). Samples were diluted in particle-free PBS to a final volume of 0.4 ml. Measurements were recorded 3 times with camera level 12 and detection threshold 5, from which the final histogram was averaged.
EV isolation. EVs were isolated from the cell supernatant 52 . Briefly, the supernatant was subjected to sequential centrifugation at 300g for 10 min at 4 °C. The supernatant was then subjected to centrifugations at 2,000g for 30 min followed by 20,000g at 45 min, both at 4 °C. The supernatant was ultracentrifuged at 100,000g for 90 min, the pellet was washed again in PBS and the EVs were pelleted at 100,000g for 90 min.
Quantification of DNA using PicoGreen. Isolated DNA was quantified using Quanti-iT PicoGreen dsDNA reagent and kit (Invitrogen) according to the manufacturer's instructions. Briefly, total DNA was diluted in the Tris-EDTA buffer supplied. The DNA concentrations were determined using λ-DNA diluted to generate a high-range standard curve. Following incubation of samples with PicoGreen for 5 min, the florescence was measured at 485 nm. Data are represented as fold induction relative to mock-infected cells.
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